Ejercicio y corazón

1. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. Exercise and Hypertension. Med Sci Sports Exerc 2004; 36:533–553.
2. Kelley GA, Kelley KS, Tran ZV.Walking, lipids, and lipoproteins: a meta-analysis of randomized controlled trials. Prev Med 2004; 38:651–661.
3. Boule NG, Haddad E, Kenny GP,Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus a meta-analysis of controlled clinical trials. JAMA 2001; 286:11–15.
4. Morris JN, Heady JA, Raffle PA, Roberts CG, Parks JW. Coronary heart-disease and physical activity of work. Lancet 1953; 265:1111–1120.
5. Tanasescu M, Leitzmann MF, Rimm EB, WillettW, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA 2002; 288:
1994–2000.
6. Schnohr P, O’Keefe JH, Marott JL, Lange P, Jensen GB. Dose of jogging and long-term mortality. J Am Coll Cardiol 2015; 65:411–419.
7. Lee D-C, Pate RR, Lavie CJ, Sui X, Church TS, Blair SN. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol 2014; 64:472–481.
8. Kokkinos P, Myers J, Faselis C, Panagiotakos DB, Doumas M, Pittaras A, Manolis A, Kokkinos JP, Karasik P, Greenberg M, PapademetriouV, Fletcher R. Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation 2010; 122:
790–797.
9. Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized
controlled trials. Am Heart J 2011; 162:571–584.e2.
10. ConnorCMO, Whellan DJ, Lee KL, Steven J, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, KitzmanDW, Blumenthal JA, David S, Miller NH, Fleg JL, Schulman KA, Mckelvie RS, Zannad F, Piña IL. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301:1439–1450.
11. Yatsuya H, Li Y, Hilawe EH, Ota A,Wang C, Chiang C, ZhangY, Uemura M,Osako A, Ozaki Y, Aoyama A Global trend in overweight and obesity and its association with cardiovascular disease incidence. Circ J 2014; 78:2807–2818.
12. Lee I-M. Physical activity and cancer prevention – data from epidemiologic studies. Med Sci Sports Exerc 2003; 35:1823–1827.
13. Laurin D, Verreault R, Lindsay J, MacPherson K, Rockwood K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol 2001; 58: 498–504.
14. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002; 22:3251–3261.
15. Clarke PM,Walter SJ, Hayen A, Mallon WJ, Heijmans J, Studdert DM. Survival of the fittest?: retrospective cohort study of the longevity of Olympic medallists in the modern era. BMJ 2012; 8308:1–8.
16. O’Donovan G, Blazevich AJ, Boreham C, Cooper AR, Crank H, Ekelund U, Fox KR, Gately P, Giles-Corti B, Gill JMR, Hamer M, McDermott I, Murphy M, Mutrie N, Reilly JJ, Saxton JM, Stamatakis E. The ABC of Physical Activity for Health: a consensus statement from the British Association of Sport and Exercise Sciences. J Sports Sci 2010; 28:573–591.
17. US Department of Health and Social Services. Physical activity guidelines for Americans. www.health.gov/paguidelines (1 March 2015) (2008).
18. Sheikh N, Papadakis M, Ghani S, Zaidi A, Gati S, Adami PE, Carre´ F, Schnell F, Wilson M, Avila P, McKennaW, Sharma S. Comparison of electrocardiographic criteria for the detection of cardiac abnormalities in elite black and white athletes. Circulation 2014; 129:1637–1649.
19. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussac I, Anastasakis A, Borjesson M, Bjørnstad HH, Carre` F, Deligiannis A, Dugmore D, Fagard R, Hoogsteen J, Mellwig KP, Panhuyzen-Goedkoop N, Solberg E, Vanhees L, Drezner J, Estes N a M, Iliceto S, Maron BJ, Peidro R, Schwartz PJ, Stein R, Thiene G, Zeppilli P, McKenna WJ. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010; 31: 243–259.
20. Sharma S, Whyte G, Elliott P, Padula M, Kaushal R, Mahon N, McKenna WJ. Electrocardiographic changes in 1000 highly trained junior elite athletes. Br J Sports Med 1999; 33:319–324.
21. Papadakis M, Basavarajaiah S, Rawlins J, Edwards C, Makan J, Firoozi S, Carby L, Sharma S. Prevalence and significance of T-wave inversions in predominantly Caucasian adolescent athletes. Eur Heart J 2009; 30:1728–1735.
22. Papadakis M, Carre F, Kervio G, Rawlins J, Panoulas VF, Chandra N, Basavarajaiah S, Carby L, Fonseca T, Sharma S. The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J 2011; 32:2304–2313.
23. Luijkx T, Cramer MJ, Prakken NHJ, Buckens CF, Mosterd A, Rienks R, Backx FJG, Mali WPTM, Velthuis BK. Sport category is an important determinant of cardiac adaptation: an MRI study. Br J Sports Med 2012; 46:1119–1124.
24. Makan J, Sharma S, Firoozi S, Whyte G, Jackson PG, Mckenna WJ. Physiological upper limits of ventricular cavity size in highly trained adolescent athletes. Heart 2005; 91: 495–499.
25. Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, Mckenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete’s heart and hypertrophic cardiomyopathy. JACC 2002; 40:1431–1436.
26. Sheikh N, Papadakis M, Carre F, Kervio G, Panoulas VF, Ghani S, Zaidi A, Gati S, Rawlins J, Wilson MG, Sharma S. Cardiac adaptation to exercise in adolescent athletes of African ethnicity: an emergent elite athletic population. Br J Sports Med 2013; 47:585–592.
27. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern 1999; 130:23–31.
28. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991; 324: 295–301.
29. Basavarajaiah S, Boraita A, Whyte G, Wilson M, Carby L, Shah A, Sharma S. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic  cardiomyopathy. J Am Coll Cardiol 2008; 51:2256–2262.
30. Rawlins J, Carre F, Kervio G, Papadakis M, Chandra N, Edwards C, Whyte GP, Sharma S. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation 2010; 121:1078–1085.
31. Zaidi A, Ghani S, Sharma R, Oxborough D, Panoulas VF, Sheikh N, Gati S, Papadakis M, Sharma S. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation 2013; 127:1783–1792.
32. Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013; 61: 1027–1040.
33. Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, Ghani S, Sheikh N, Zaidi A, Wilson M, Wilson M, Papadakis M, Carre´ F, Sharma S Increased left ventricular trabeculation in highly trained athletes: doweneed more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart 2013; 99:401–408.
34. Maron BJ, Doerer JJ, Haas TS, TierneyDM,Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation 2009;119:1085–1092.
35. Harmon KG, Drezner JA, WilsonMG, Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Br J Sports Med 2014; 48:1185–1192.
36. James J, Merghani A, Sharma S. Sudden death in Marathon runners. Cardiac Electrophysiol Clin 2013; 5:43–51.
37. Berdowski J, De Beus MF, Blom M, Bardai A, Bots ML, Doevendans P a, Grobbee DE, Tan HL, Tijssen JGP, Koster RW, Mosterd A. Exercise-related out-of-hospital
cardiac arrest in the general population: incidence and prognosis. Eur Heart J 2013;34:3616–3623.
38. Marijon E, Tafflet M, Celermajer DS, Dumas F, Perier M-C, Mustafic H, Toussaint J-F, Desnos M, Rieu M,Benameur N, Le Heuzey J-Y, Empana J-P, Jouven X. Sports-related sudden death in the general population. Circulation 2011; 124:672–681.
39. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes. JAMA 2006; 296:1593–1601.
40. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M, Heidbu¨chel H, Bjo¨rnstad HH, Gielen S, Mezzani A, Corrado D, Pelliccia A, Vanhees L. Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitatio. Eur J Cardiovasc Prev Rehabil 2011; 18:446–458.
41. Van de Sande DAJP, Hoogeveen A, Hoogsteen J, KempsHMC. The diagnostic accuracy of exercise electrocardiography in asymptomatic recreational and competitive athletes. Scand J Med Sci Sports 2015.
42. Ermolao A, Roman F, Gasperetti A, Varnier M, Bergamin M, Zaccaria M. Coronary CT angiography in asymptomatic middle-aged athletes with ST segment anomalies during maximal exercise test. Scand J Med Sci Sports 2015.
43. Kim JH, Malhotra R, Chiampas G, d’Hemecourt P, Troyanos C, Cianca J, Smith RN, Wang TJ, Roberts WO, Thompson PD, Baggish AL. Cardiac arrest during long distance running races. N Engl J Med 2012;366:130–140.
44. Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, Gaze D, Thompson PD. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010; 56:169–176.
45. Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif J-C, Brugada J, Nattel S, Mont L. Cardiac arrhythmogenic remodeling in a rat model of long-term
intensive exercise training. Circulation 2011; 123:13–22.
46. Breuckmann F, Lehmann N, Ladd S, Schmermund A, Schlosser T, Jo K, Erbel R. Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 2009; 251:50–57.
47. Mo¨hlenkamp S, Lehmann N, Breuckmann F, Bro¨cker-Preuss M, Nassenstein K, Halle M, Budde T, Mann K, Barkhausen J, Heusch G, Jo¨ ckel K-H, Erbel R. Running: the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008; 29:1903–1910.
48. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace 2009;11:1156–1159.
49. Andersen K, Farahmand B, Ahlbom A, Held C, Ljunghall S, Michae¨lsson K, Sundstro¨m J. Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. Eur Heart J 2013; 34:3624–3631.
50. Elosua R, Arquer A, Mont L, Sambola A, Molina L, Garcı´a-Mora´n E, Brugada J, Marrugat J. Sport practice and the risk of lone atrial fibrillation: a case-control study. Int J Cardiol 2006; 108:332–337.
51. Drca N,Wolk A, Jensen-Urstad M, Larsson SC. Atrial fibrillation is associated with different levels of physical activity levels at different ages in men. Heart 2014; 100:1037–1042.
52. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M, Vidal B, Scalise A, Tejeira A, Berruezo A, Brugada J. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008; 10:15–20.
53. Guasch E, Benito B, Qi X, Cifelli C, Naud P, Shi Y, Mighiu A, Tardif J-C, Tadevosyan A, Chen Y, Gillis M-A, Iwasaki Y-K, Dobrev D, Mont L, Heximer S, Nattel S. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol 2013; 62:68–77.
54. Baldesberger S, Bauersfeld U, Candinas R, Seifert B, Zuber M, Ritter M, Jenni R, Oechslin E, Luthi P, Scharf C, Marti B, Attenhofer Jost CH. Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists. Eur Heart J 2008; 29:71–78.
55. Heidbüchel H. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias role of an electrophysiologic study in risk stratification. Eur Heart J 2003; 24:1473–1480.
56. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J, Macisaac AI, Heidbu¨chel H, Prior DL. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012; 33:998–1006.
57. Pelliccia A, Kinoshita N, Pisicchio C,Quattrini F, Dipaolo FM, Ciardo R, Giacinto BDi, Guerra E, Blasiis E De, Casasco M, Culasso F, Maron BJ. Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes. JACC 2010; 55:1619–1625.
58. Bhella PS, Hastings JL, Fujimoto N, Shibata S, Carrick-Ranson G, Palmer MD, Boyd KN, Adams-Huet B, Levine BD. Impact of lifelong exercise “dose” on left ventricular compliance and distensibility. J Am Coll Cardiol 2014; 64:1257–1266.
59. Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS, Bougouin W, Combes N, Hermine O, Empana J-P, Rey G, Toussaint J-F, Jouven X Mortality of French participants in the Tour de France (1947–2012). Eur Heart J 2013; 34:3145–3150.
60. Luijkx T, Velthuis BK, Backx FJG, Buckens CFM, Prakken NHJ, Rienks R, Mali WPTM, Cramer MJ. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol 2015; 167:664–668.
61. Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-
Goedkoop NM, Pigozzi F, SchänzerW, Vanhees L. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006;13:687–694. Page 10 of 10 S. Sharma et al. Downloaded from by guest on April 7, 2015